TGNA
53
2
F
43
-8
KMX
58
3
DLTR
34
-4
MPC
47
3
BIIB
26
2
IR
63
3
L
62
2
PDCO
35
-3
FRT
39
-2
EW
37
-2
USB
50
2
SRE
63
-3
ABT
57
-5
DE
46
3
BAC
50
-3
CF
59
3
AIV
68
-4
CMCSA
48
2
BEN
45
3
TGNA
53
2
F
43
-8
KMX
58
3
DLTR
34
-4
MPC
47
3
BIIB
26
2
IR
63
3
L
62
2
PDCO
35
-3
FRT
39
-2
EW
37
-2
USB
50
2
SRE
63
-3
ABT
57
-5
DE
46
3
BAC
50
-3
CF
59
3
AIV
68
-4
CMCSA
48
2
BEN
45
3
Financhill
Back

Bright Minds Biosciences 10K Form

Sell
25

DRUG
Bright Minds Biosciences

Last Price:
32.67
Seasonality Move:
-10.65%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DRUG News And Ratings

See the #1 stock for the next 7 days that we like better than DRUG

DRUG Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $193K
Price / Cash Flow: 0
Annual Sales: $1.00
Price / Book: 36.52

Profitability

EPS (TTM): -0.68110
Net Income (TTM): $-2.63M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Bright Minds Biosciences Earnings Forecast

Key Bright Minds Biosciences Financial Ratios

  • Per Share Earnings over the last 4 years have been positive in 1 years.

Bright Minds Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: DRUG
Website: brightmindsbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

DRUG Technical Analysis vs Fundamental Analysis

Sell
25
Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy or a Sell?